CorMedix Approves Key Governance and Incentive Changes
Here's Why We Think CorMedix Inc.'s (NASDAQ:CRMD) CEO Compensation Looks Fair for the Time Being
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium
Rainbows and Unicorns: CorMedix Inc. (NASDAQ:CRMD) Analysts Just Became A Lot More Optimistic
CorMedix Inc. (NASDAQ:CRMD) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates
While Shareholders of CorMedix (NASDAQ:CRMD) Are in the Black Over 1 Year, Those Who Bought a Week Ago Aren't so Fortunate
take it ！